Literature DB >> 23125078

Nkx2-1: a novel tumor biomarker of lung cancer.

Li Yang1, Min Lin, Wen-jing Ruan, Liang-liang Dong, En-guo Chen, Xiao-hong Wu, Ke-jing Ying.   

Abstract

Nkx2-1 (Nkx homeobox-1 gene), also known as TTF-1 (thyroid transcription factor-1), is a tissue-specific transcription factor of the thyroid, lung, and ventral forebrain. While it has been shown to play a critical role in lung development and lung cancer differentiation and morphogenesis, molecular mechanisms mediating Nkx2-1 cell- and tissue-specific expression in normal and cancerous lungs have yet to be fully elucidated. The recent identification of prognostic biomarkers in lung cancer, particularly in lung adenocarcinoma (ADC), and the different reactivity of patients to chemotherapeutic drugs have opened new avenues for evaluating patient survival and the development of novel effective therapeutic strategies. The function of Nkx2-1 as a proto-oncogene was recently characterized and the gene is implicated as a contributory factor in lung cancer development. In this review, we summarize the role of this transcription factor in the development, diagnosis, and prognosis of lung cancer in the hope of providing insights into the utility of Nkx2-1 as a novel biomarker of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23125078      PMCID: PMC3494024          DOI: 10.1631/jzus.B1100382

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  93 in total

1.  Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group study.

Authors:  H L West; J J Crowley; R B Vance; W A Franklin; R B Livingston; S R Dakhil; J K Giguere; S E Rivkin; M Kraut; K Chansky; D R Gandara
Journal:  Ann Oncol       Date:  2005-04-28       Impact factor: 32.976

2.  Transcriptional stimulation of the surfactant protein B gene by STAT3 in respiratory epithelial cells.

Authors:  Cong Yan; Angela Naltner; Michelle Martin; Michael Naltner; Jessica M Fangman; Okyanus Gurel
Journal:  J Biol Chem       Date:  2002-01-11       Impact factor: 5.157

3.  Expression of thyroid transcription factor-1 in malignant pleural effusions.

Authors:  Andras Khoor; Angela L Byrd-Gloster; Santo V Nicosia
Journal:  Pathol Oncol Res       Date:  2010-09-17       Impact factor: 3.201

4.  Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency.

Authors:  Heiko Krude; Barbara Schütz; Heike Biebermann; Arpad von Moers; Dirk Schnabel; Heidi Neitzel; Holger Tönnies; Dagmar Weise; Antony Lafferty; Siegfried Schwarz; Mario DeFelice; Andreas von Deimling; Frank van Landeghem; Roberto DiLauro; Annette Grüters
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

5.  Two functionally distinct forms of NKX2.1 protein are expressed in the pulmonary epithelium.

Authors:  C Li; J Cai; Q Pan; P Minoo
Journal:  Biochem Biophys Res Commun       Date:  2000-04-13       Impact factor: 3.575

6.  Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.

Authors:  Changgong Li; Nian-Ling Zhu; Rosemarie C Tan; Philip L Ballard; Rik Derynck; Parviz Minoo
Journal:  J Biol Chem       Date:  2002-08-02       Impact factor: 5.157

7.  Mutation of a lysine residue in a homeodomain generates dominant negative thyroid transcription factor 1.

Authors:  Li Yang; Dong Yan; Molly Bruggeman; Hong Du; Cong Yan
Journal:  Biochemistry       Date:  2004-10-05       Impact factor: 3.162

8.  BR22, a 26 kDa thyroid transcription factor-1 associated protein (TAP26), is expressed in human lung cells.

Authors:  M C W Yang; B Wang; J C Weissler; L R Margraf; Y S Yang
Journal:  Eur Respir J       Date:  2003-07       Impact factor: 16.671

9.  The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis.

Authors:  R J Bohinski; R Di Lauro; J A Whitsett
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

10.  Airway epithelial transcription factor NK2 homeobox 1 inhibits mucous cell metaplasia and Th2 inflammation.

Authors:  Yutaka Maeda; Gang Chen; Yan Xu; Hans Michael Haitchi; Lingling Du; Angela R Keiser; Peter H Howarth; Donna E Davies; Stephen T Holgate; Jeffrey A Whitsett
Journal:  Am J Respir Crit Care Med       Date:  2011-08-15       Impact factor: 21.405

View more
  15 in total

1.  Association between gene expression profiles and clinical outcome of pemetrexed-based treatment in patients with advanced non-squamous non-small cell lung cancer: exploratory results from a phase II study.

Authors:  Dean A Fennell; Scott P Myrand; Tuan S Nguyen; David Ferry; Keith M Kerr; Perry Maxwell; Stephen D Moore; Carla Visseren-Grul; Mayukh Das; Marianne C Nicolson
Journal:  PLoS One       Date:  2014-09-24       Impact factor: 3.240

2.  The NANCI-Nkx2.1 gene duplex buffers Nkx2.1 expression to maintain lung development and homeostasis.

Authors:  Michael J Herriges; David J Tischfield; Zheng Cui; Michael P Morley; Yumiao Han; Apoorva Babu; Su Li; MinMin Lu; Isis Cendan; Benjamin A Garcia; Stewart A Anderson; Edward E Morrisey
Journal:  Genes Dev       Date:  2017-05-25       Impact factor: 11.361

Review 3.  Nkx2-3-A Slippery Slope From Development Through Inflammation Toward Hematopoietic Malignancies.

Authors:  Dóra Vojkovics; Zoltán Kellermayer; Béla Kajtár; Giovanna Roncador; Áron Vincze; Péter Balogh
Journal:  Biomark Insights       Date:  2018-02-06

4.  Thyroid transcription factor 1 and p63 expression is associated with survival outcome in patients with non-small cell lung cancer treated with erlotinib.

Authors:  Martin Svaton; Ondrej Fiala; Gabriela Krakorova; Jiri Blazek; Karolina Hurdalkova; Magda Barinova; Petr Mukensnabl; Milos Pesek
Journal:  Oncol Lett       Date:  2020-05-21       Impact factor: 2.967

5.  NKX6.1 Represses Tumorigenesis, Metastasis, and Chemoresistance in Colorectal Cancer.

Authors:  Hsin-Hua Chung; Chun-Te Lee; Je-Ming Hu; Yu-Ching Chou; Ya-Wen Lin; Yu-Lueng Shih
Journal:  Int J Mol Sci       Date:  2020-07-19       Impact factor: 5.923

6.  DeePaN: deep patient graph convolutional network integrating clinico-genomic evidence to stratify lung cancers for immunotherapy.

Authors:  Chao Fang; Dong Xu; Jing Su; Jonathan R Dry; Bolan Linghu
Journal:  NPJ Digit Med       Date:  2021-02-02

7.  Informative gene selection and the direct classification of tumors based on relative simplicity.

Authors:  Yuan Chen; Lifeng Wang; Lanzhi Li; Hongyan Zhang; Zheming Yuan
Journal:  BMC Bioinformatics       Date:  2016-01-20       Impact factor: 3.169

8.  Network modeling of kinase inhibitor polypharmacology reveals pathways targeted in chemical screens.

Authors:  Oana Ursu; Sara J C Gosline; Neil Beeharry; Lauren Fink; Vikram Bhattacharjee; Shao-Shan Carol Huang; Yan Zhou; Tim Yen; Ernest Fraenkel
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

9.  LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.

Authors:  Yin Zhang; Yong-Xin Huang; Dan-Lan Wang; Bing Yang; Hai-Yan Yan; Le-Hang Lin; Yun Li; Jie Chen; Li-Min Xie; Yong-Sheng Huang; Jian-You Liao; Kai-Shun Hu; Jie-Hua He; Phei Er Saw; Xiaoding Xu; Dong Yin
Journal:  Theranostics       Date:  2020-08-29       Impact factor: 11.556

10.  Predicting Deep Learning Based Multi-Omics Parallel Integration Survival Subtypes in Lung Cancer Using Reverse Phase Protein Array Data.

Authors:  Satoshi Takahashi; Ken Asada; Ken Takasawa; Ryo Shimoyama; Akira Sakai; Amina Bolatkan; Norio Shinkai; Kazuma Kobayashi; Masaaki Komatsu; Syuzo Kaneko; Jun Sese; Ryuji Hamamoto
Journal:  Biomolecules       Date:  2020-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.